Twenty-first century genomics for sports medicine: what does it all mean?

Anthony Webborn, Paul Dijkstra

Research output: Contribution to journalArticlepeer-review


We can easily be left behind by the explosion in technological developments in medicine—or is it just a sign of getting older? Many of us will remember a time before MRI were readily available, and having to learn what fat suppressed images, T1s and T2s actually meant. Genomics is another example of a rapidly expanding technological develop- ment with major implications for medi- cine, and even experienced clinicians (many without formal training in molecu- lar biology) are struggling to understand this. It requires learning a whole new lan- guage. The sequencing of the 3.2 billion nucleotides that compose the human genome was first completed only in 2003, at an estimated cost of $2.7 billion. At the time, it was simply something of interest, unlikely to influence our working lives any time soon. Now, in just over a decade, it is possible to sequence the whole genome for $1000.
Original languageEnglish
Pages (from-to)1481-1482
Number of pages2
JournalBritish Journal of Sports Medicine
Issue number23
Publication statusPublished - 18 Nov 2015


Dive into the research topics of 'Twenty-first century genomics for sports medicine: what does it all mean?'. Together they form a unique fingerprint.

Cite this